Lv1
40 积分 2025-09-28 加入
The role of noninvasive scoring systems for predicting cardiovascular disease risk in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis
2个月前
已完结
Sa1613: LIVER AND CARDIOVASCULAR RISK ASSESSMENT USING THE NONALCOHOLIC FATTY LIVER DISEASE FIBROSIS SCORE IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS
2个月前
已完结
Liver Fibrosis and Cardiovascular Events
3个月前
已关闭
Associations of MAFLD and MAFLD subtypes with the risk of the incident myocardial infarction and stroke
3个月前
已完结
Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease
3个月前
已完结
Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis
4个月前
已完结
Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease
5个月前
已完结
Association between liver fibrosis, plasma volume status, and cardiovascular mortality: The Hiroshima Study on Glucose Metabolism and Cardiovascular Diseases
5个月前
已完结
Impact of NAFLD and Fibrosis on Adverse Cardiovascular Events in Patients With Hypertension
5个月前
已完结
Predictability of noninvasive liver fibrosis score for cardiac events in patients with nonalcoholic fatty liver disease
5个月前
已完结
皖公网安备34019202002308
